Application of Convergent Science and Technology toward Ocular Disease Treatment

Author:

Bal-Öztürk Ayça12ORCID,Özcan-Bülbül Ece3ORCID,Gültekin Hazal Ezgi4,Cecen Berivan56ORCID,Demir Ebru78ORCID,Zarepour Atefeh9ORCID,Cetinel Sibel78ORCID,Zarrabi Ali9ORCID

Affiliation:

1. Department of Stem Cell and Tissue Engineering, Institute of Health Sciences, Istinye University, Istanbul 34396, Türkiye

2. Department of Analytical Chemistry, Faculty of Pharmacy, Istinye University, Istanbul 34396, Türkiye

3. Department of Pharmaceutical Technology, Faculty of Pharmacy, Istinye University, Istanbul 34396, Türkiye

4. Department of Pharmaceutical Technology, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Türkiye

5. Department of Mechanical Engineering, Rowan University, Glassboro, NJ 08028, USA

6. Department of Biomedical Engineering, Rowan University, Glassboro, NJ 08028, USA

7. Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Türkiye

8. Molecular Biology, Genetics and Bioengineering Program, Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Türkiye

9. Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul 34396, Türkiye

Abstract

Eyes are one of the main critical organs of the body that provide our brain with the most information about the surrounding environment. Disturbance in the activity of this informational organ, resulting from different ocular diseases, could affect the quality of life, so finding appropriate methods for treating ocular disease has attracted lots of attention. This is especially due to the ineffectiveness of the conventional therapeutic method to deliver drugs into the interior parts of the eye, and the also presence of barriers such as tear film, blood-ocular, and blood-retina barriers. Recently, some novel techniques, such as different types of contact lenses, micro and nanoneedles and in situ gels, have been introduced which can overcome the previously mentioned barriers. These novel techniques could enhance the bioavailability of therapeutic components inside the eyes, deliver them to the posterior side of the eyes, release them in a controlled manner, and reduce the side effects of previous methods (such as eye drops). Accordingly, this review paper aims to summarize some of the evidence on the effectiveness of these new techniques for treating ocular disease, their preclinical and clinical progression, current limitations, and future perspectives.

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Reference179 articles.

1. Addo, R.T. (2016). Ocular Drug Delivery: Advances, Challenges and Applications, Springer International Publishing.

2. Grumezescu, A.M. (2018). Design of Nanostructures for Versatile Therapeutic Applications, William Andrew Publishing.

3. Nanotechnology-based strategies for treatment of ocular disease;Weng;Acta Pharm. Sin. B,2017

4. Mozafari, M. (2020). Nanoengineered Biomaterials for Advanced Drug Delivery, Elsevier.

5. Liposomes and nanotechnology in drug development: Focus on ocular targets;Honda;Int. J. Nanomed.,2013

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3